• PDF: Delivered by email usually within 4 to 8 UK business hours.
  • PRINT/CD-ROM: Despatched within 1 to 2 working days.

OTC Pharmaceuticals
Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide

  • Publication Date:May 2010
  • Publisher:Datamonitor
  • Product Type: Report
  • Pages:178

OTC Pharmaceuticals Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide

Datamonitor's OTC Pharmaceuticals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in Brazil, Hungary, Mexico, Poland, South Africa, and Taiwan. The report includes easily comparable data on market value, volume, segmentation and market share for the advanced emerging markets otc pharmaceuticals markets, plus full five-year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Scope of the Report

  • Contains an executive summary and data on value, volume and segmentation
  • Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Compares data from Brazil, Hungary, Mexico, Poland, South Africa and Taiwan, alongside individual chapters on each country.
  • Includes a five-year forecast of the industry

Highlights

The advanced emerging market countries contributed $10.7billion to the global OTC pharmaceuticals industry in 2008, with a CAGR of 6.8% between 2004 and 2008.

These countries are expected to reach a value of $13.9 billion in 2013, with a CAGR of 5.5% over the 2008-13 period.

Brazil is the leading country in the OTC pharmaceuticals industry, with market revenues of $3.6 billion in 2008.

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

In this report, the OTC pharmaceuticals market values consists of the total sales of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). Market's values are calculated using retail selling price (RSP) and include any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant annual average exchange rates.

  • Chapter 1 Introduction
    • 1.1 What is this report about?
    • 1.2 Who is the target reader?
    • 1.3 How to use this report
    • 1.4 Definitions
  • Chapter 2 Advanced Emerging Markets Otc Pharmaceuticals Industry Outlook
  • Chapter 3 Otc Pharmaceuticals in Brazil
    • 3.1 Market Overview
    • 3.2 Market Value
    • 3.3 Market Segmentation I
    • 3.4 Market Segmentation II
    • 3.5 Market Share
    • 3.6 Five Forces Analysis
    • 3.7 Leading Companies
    • 3.8 Distribution
    • 3.9 Market Forecasts
    • 3.10 Macroeconomic Indicators
  • Chapter 4 Otc Pharmaceuticals in Hungary
    • 4.1 Market Overview
    • 4.2 Market Value
    • 4.3 Market Segmentation I
    • 4.4 Market Segmentation II
    • 4.5 Market Share
    • 4.6 Five Forces Analysis
    • 4.7 Leading Companies
    • 4.8 Distribution
    • 4.9 Market Forecasts
    • 4.10 Macroeconomic Indicators
  • Chapter 5 Otc Pharmaceuticals in Mexico
    • 5.1 Market Overview
    • 5.2 Market Value
    • 5.3 Market Segmentation I
    • 5.4 Market Segmentation II
    • 5.5 Market Share
    • 5.6 Five Forces Analysis
    • 5.7 Leading Companies
    • 5.8 Distribution
    • 5.9 Market Forecasts
    • 5.10 Macroeconomic Indicators
  • Chapter 6 Otc Pharmaceuticals in Poland
    • 6.1 Market Overview
    • 6.2 Market Value
    • 6.3 Market Segmentation I
    • 6.4 Market Segmentation II
    • 6.5 Market Share
    • 6.6 Five Forces Analysis
    • 6.7 Leading Companies
    • 6.8 Distribution
    • 6.9 Market Forecasts
    • 6.10 Macroeconomic Indicators
  • Chapter 7 Otc Pharmaceuticals in South Africa
    • 7.1 Market Overview
    • 7.2 Market Value
    • 7.3 Market Segmentation
    • 7.4 Market Share
    • 7.5 Five Forces Analysis
    • 7.6 Leading Companies
    • 7.7 Distribution
    • 7.8 Market Forecasts
    • 7.9 Macroeconomic Indicators
  • Chapter 8 Otc Pharmaceuticals in Taiwan
    • 8.1 Market Overview
    • 8.2 Market Value
    • 8.3 Market Segmentation I
    • 8.4 Market Segmentation II
    • 8.5 Market Share
    • 8.6 Five Forces Analysis
    • 8.7 Leading Companies
    • 8.8 Distribution
    • 8.9 Market Forecasts
    • 8.10 Macroeconomic Indicators
  • Chapter 9 Appendix
    • 9.1 Data Research Methodology
  • List of Tables
    • Table 1: Advanced emerging markets OTC pharmaceuticals industry, revenue ($bn), 2004-13
    • Table 2: Advanced emerging markets OTC pharmaceuticals industry, revenue by country ($bn), 2004-08
    • Table 3: Advanced emerging markets OTC pharmaceuticals industry forecast, revenue by country ($bn), 2008-13
    • Table 4: Brazil OTC Pharmaceuticals Market Value: $ billion, 2004-2008
    • Table 5: Brazil OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
    • Table 6: Brazil OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
    • Table 7: Brazil OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Table 8: Key Facts: Johnson & Johnson
    • Table 9: Key Financials: Johnson & Johnson
    • Table 10: Key Facts: Sanofi-Aventis SA
    • Table 11: Key Financials: Sanofi-Aventis SA
    • Table 12: Key Facts: Abbott Laboratories
    • Table 13: Key Financials: Abbott Laboratories
    • Table 14: Brazil OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Table 15: Brazil OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
    • Table 16: Brazil Size of Population (million) , 2004-2008
    • Table 17: Brazil GDP (Constant 2000 Prices, $ billion), 2004-2008
    • Table 18: Brazil Inflation, 2004-2008
    • Table 19: Brazil Exchange Rate, 2004-2008
    • Table 20: Hungary OTC Pharmaceuticals Market Value: $ million, 2004-2008
    • Table 21: Hungary OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
    • Table 22: Hungary OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
    • Table 23: Hungary OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Table 24: Key Facts: Johnson & Johnson
    • Table 25: Key Financials: Johnson & Johnson
    • Table 26: Key Facts: Beres Pharmaceuticals Co. Ltd
    • Table 27: Key Facts: EGIS Pharmaceuticals Plc
    • Table 28: Key Financials: EGIS Pharmaceuticals Plc
    • Table 29: Hungary OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Table 30: Hungary OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013
    • Table 31: Hungary Size of Population (million) , 2004-2008
    • Table 32: Hungary GDP (Constant 2000 Prices, $ billion), 2004-2008
    • Table 33: Hungary Inflation, 2004-2008
    • Table 34: Hungary Exchange Rate, 2004-2008
    • Table 35: Mexico OTC Pharmaceuticals Market Value: $ billion, 2004-2008
    • Table 36: Mexico OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
    • Table 37: Mexico OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
    • Table 38: Mexico OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Table 39: Key Facts: Bayer AG
    • Table 40: Key Financials: Bayer AG
    • Table 41: Key Facts: Johnson & Johnson
    • Table 42: Key Financials: Johnson & Johnson
    • Table 43: Key Facts: Boehringer Ingelheim GmbH
    • Table 44: Key Financials: Boehringer Ingelheim GmbH
    • Table 45: Mexico OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Table 46: Mexico OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
    • Table 47: Mexico Size of Population (million) , 2004-2008
    • Table 48: Mexico GDP (Constant 2000 Prices, $ billion), 2004-2008
    • Table 49: Mexico Inflation, 2004-2008
    • Table 50: Mexico Exchange Rate, 2004-2008
    • Table 51: Poland OTC Pharmaceuticals Market Value: $ billion, 2004-2008
    • Table 52: Poland OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
    • Table 53: Poland OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
    • Table 54: Poland OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Table 55: Key Facts: GlaxoSmithKline Plc
    • Table 56: Key Financials: GlaxoSmithKline Plc
    • Table 57: Key Facts: US Pharmacia SP. Z O.O
    • Table 58: Key Facts: Herbapol wroclaw SA
    • Table 59: Poland OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Table 60: Poland OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
    • Table 61: Poland Size of Population (million) , 2004-2008
    • Table 62: Poland GDP (Constant 2000 Prices, $ billion), 2004-2008
    • Table 63: Poland Inflation, 2004-2008
    • Table 64: Poland Exchange Rate, 2004-2008
    • Table 65: South Africa OTC Pharmaceuticals Market Value: $ million, 2004-2008
    • Table 66: South Africa OTC Pharmaceuticals Market Segmentation: % Share, by Value, 2008
    • Table 67: South Africa OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Table 68: Key Facts: Weleda Group
    • Table 69: Key Facts: Johnson & Johnson
    • Table 70: Key Financials: Johnson & Johnson
    • Table 71: South Africa OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Table 72: South Africa OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013
    • Table 73: South Africa Size of Population (million) , 2004-2008
    • Table 74: South Africa GDP (Constant 2000 Prices, $ billion), 2004-2008
    • Table 75: South Africa Inflation, 2004-2008
    • Table 76: South Africa Exchange Rate, 2004-2008
    • Table 77: Taiwan OTC Pharmaceuticals Market Value: $ million, 2004-2008
    • Table 78: Taiwan OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
    • Table 79: Taiwan OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
    • Table 80: Taiwan OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Table 81: Key Facts: China Chemical & Pharmaceuticals Co Ltd
    • Table 82: Key Facts: Sinphar Pharmaceutical Co., Ltd
    • Table 83: Key Financials: Sinphar Pharmaceutical Co., Ltd
    • Table 84: Key Facts: Daiichi Sankyo Company, Limited
    • Table 85: Taiwan OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Table 86: Taiwan OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013
    • Table 87: Taiwan Size of Population (million) , 2004-2008
    • Table 88: Taiwan GDP (Constant 2000 Prices, $ billion), 2004-2008
    • Table 89: Taiwan Inflation, 2004-2008
    • Table 90: Taiwan Exchange Rate, 2004-2008
  • List of Figures
    • Figure 1: Advanced emerging markets OTC pharmaceuticals industry, revenue ($bn), 2004-13
    • Figure 2: Advanced emerging markets OTC pharmaceuticals industry, country analysis (%), 2004-13
    • Figure 3: Advanced emerging markets OTC pharmaceuticals industry, revenue by country ($bn), 2004-08
    • Figure 4: Advanced emerging markets OTC pharmaceuticals industry forecast, revenue by country ($bn), 2008-13
    • Figure 5: Brazil OTC Pharmaceuticals Market Value: $ billion, 2004-2008
    • Figure 6: Brazil OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
    • Figure 7: Brazil OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
    • Figure 8: Brazil OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Figure 9: Forces Driving Competition in the OTC Pharmaceuticals Market in Brazil, 2008
    • Figure 10: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Brazil, 2008
    • Figure 11: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Brazil, 2008
    • Figure 12: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Brazil, 2008
    • Figure 13: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Brazil, 2008
    • Figure 14: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Brazil, 2008
    • Figure 15: Revenues & Profitability: Johnson & Johnson
    • Figure 16: Revenues & Profitability: Sanofi-Aventis SA
    • Figure 17: Revenues & Profitability: Abbott Laboratories
    • Figure 18: Brazil OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Figure 19: Brazil OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
    • Figure 20: Hungary OTC Pharmaceuticals Market Value: $ million, 2004-2008
    • Figure 21: Hungary OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
    • Figure 22: Hungary OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
    • Figure 23: Hungary OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Figure 24: Forces Driving Competition in the OTC Pharmaceuticals Market in Hungary, 2008
    • Figure 25: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Hungary, 2008
    • Figure 26: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Hungary, 2008
    • Figure 27: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Hungary, 2008
    • Figure 28: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Hungary, 2008
    • Figure 29: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Hungary, 2008
    • Figure 30: Revenues & Profitability: Johnson & Johnson
    • Figure 31: Revenues & Profitability: EGIS Pharmaceuticals Plc
    • Figure 32: Hungary OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Figure 33: Hungary OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013
    • Figure 34: Mexico OTC Pharmaceuticals Market Value: $ billion, 2004-2008
    • Figure 35: Mexico OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
    • Figure 36: Mexico OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
    • Figure 37: Mexico OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Figure 38: Forces Driving Competition in the OTC Pharmaceuticals Market in Mexico, 2008
    • Figure 39: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Mexico, 2008
    • Figure 40: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Mexico, 2008
    • Figure 41: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Mexico, 2008
    • Figure 42: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Mexico, 2008
    • Figure 43: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Mexico, 2008
    • Figure 44: Revenues & Profitability: Bayer AG
    • Figure 45: Revenues & Profitability: Johnson & Johnson
    • Figure 46: Revenues & Profitability: Boehringer Ingelheim GmbH
    • Figure 47: Mexico OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Figure 48: Mexico OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
    • Figure 49: Poland OTC Pharmaceuticals Market Value: $ billion, 2004-2008
    • Figure 50: Poland OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
    • Figure 51: Poland OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
    • Figure 52: Poland OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Figure 53: Forces Driving Competition in the OTC Pharmaceuticals Market in Poland, 2008
    • Figure 54: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Poland, 2008
    • Figure 55: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Poland, 2008
    • Figure 56: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Poland, 2008
    • Figure 57: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Poland, 2008
    • Figure 58: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Poland, 2008
    • Figure 59: Revenues & Profitability: GlaxoSmithKline Plc
    • Figure 60: Poland OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Figure 61: Poland OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
    • Figure 62: South Africa OTC Pharmaceuticals Market Value: $ million, 2004-2008
    • Figure 63: South Africa OTC Pharmaceuticals Market Segmentation: % Share, by Value, 2008
    • Figure 64: South Africa OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Figure 65: Forces Driving Competition in the OTC Pharmaceuticals Market in South Africa, 2008
    • Figure 66: Drivers of Buyer Power in the OTC Pharmaceuticals Market in South Africa, 2008
    • Figure 67: Drivers of Supplier Power in the OTC Pharmaceuticals Market in South Africa, 2008
    • Figure 68: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in South Africa, 2008
    • Figure 69: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in South Africa, 2008
    • Figure 70: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in South Africa, 2008
    • Figure 71: Revenues & Profitability: Johnson & Johnson
    • Figure 72: South Africa OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Figure 73: South Africa OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013
    • Figure 74: Taiwan OTC Pharmaceuticals Market Value: $ million, 2004-2008
    • Figure 75: Taiwan OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008
    • Figure 76: Taiwan OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008
    • Figure 77: Taiwan OTC Pharmaceuticals Market Share: % Share, by Value, 2008
    • Figure 78: Forces Driving Competition in the OTC Pharmaceuticals Market in Taiwan, 2008
    • Figure 79: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Taiwan, 2008
    • Figure 80: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Taiwan, 2008
    • Figure 81: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Taiwan, 2008
    • Figure 82: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Taiwan, 2008
    • Figure 83: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Taiwan, 2008
    • Figure 84: Revenues & Profitability: Sinphar Pharmaceutical Co., Ltd
    • Figure 85: Taiwan OTC Pharmaceuticals Distribution: % Share, by Value, 2008
    • Figure 86: Taiwan OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013
+44 20 8816 8548

Ask a question about OTC Pharmaceuticals

Enter the characters you see in the picture below
Captcha